Lipid Profile during Antihypertensive Treatment A. LibrettiM. CatalanoSLIP study group OriginalPaper 22 October 2012 Pages: 16 - 23
Treatment of Hypertension in the Elderly H. HolzgreveM. Middeke OriginalPaper 22 October 2012 Pages: 24 - 31
Influence of Antihypertensive Drugs on Exercise Capacity R. FagardJ. StaessenA. Amery OriginalPaper 22 October 2012 Pages: 32 - 36
General Considerations When Treating Hypertension Lennart Hansson OriginalPaper 22 October 2012 Pages: 37 - 39
Pharmacological Aspects of Calcium Antagonism Winifred G. Nayler OriginalPaper 22 October 2012 Pages: 40 - 47
Cardiovascular Benefits of Antihypertensive Therapy Postacute Myocardial Infarction Peter Sleight OriginalPaper 22 October 2012 Pages: 48 - 53
Postinfarct Treatment with Verapamil Jørgen Fischer Hansen OriginalPaper 22 October 2012 Pages: 54 - 60
Hypertension and Diastolic Function E. Agabiti-RoseiM. L. Muiesan OriginalPaper 22 October 2012 Pages: 61 - 67
Mechanical Function and Histological Structure of the Arterial Wall Michel E. SafarBernard I. Lévy OriginalPaper 22 October 2012 Pages: 68 - 74
Effect of Verapamil on Atherosclerosis Gastone LeonettiLorena SampieriGabriella Comerio OriginalPaper 22 October 2012 Pages: 75 - 81
Arterial Compliance and Blood Pressure S. J. MarchaisA. P. GuerinGérard London OriginalPaper 22 October 2012 Pages: 82 - 87
Effects of Angiotensin Converting Enzyme Inhibitors on Left Ventricular Hypertrophy Carmine MoriscoLuigi ArgenzianoBruno Trimarco OriginalPaper 22 October 2012 Pages: 88 - 94
White Coat Hypertension and Related Phenomena Joan Ocón-PujadasJosé Mora-Maciá OriginalPaper 22 October 2012 Pages: 95 - 102
Effects of Calcium Antagonists on Adrenaline-Induced Hypokalaemia Albert MimranJean RibsteinJoelle Sissmann OriginalPaper 22 October 2012 Pages: 103 - 107
The Kidney and Arterial Hypertension Luis M. RuilopeCarlos CampoVicente Lahera OriginalPaper 22 October 2012 Pages: 108 - 112
Long Term Effects of Sustained Release Verapamil on the Renal and Systemic Haemodynamic Parameters in Hypertensive Patients with Mild to Severe Chronic Renal Failure Dominique C. SchohnH. A. JahnM. Maareck OriginalPaper 22 October 2012 Pages: 113 - 120
Calcium Antagonists and ACE Inhibitors Thomas F. LüscherZhihong Yang OriginalPaper 22 October 2012 Pages: 121 - 132
Stress Response and Antihypertensive Treatment P. NazzaroM. MerloA. Pirrelli OriginalPaper 22 October 2012 Pages: 133 - 141
Individualised Selection of Antihypertensive Therapy L. H. Opie OriginalPaper 22 October 2012 Pages: 142 - 148
The Inter-Relationship between Insulin Resistance and Hypertension A. SalvettiG. BrogiG. P. Bernini OriginalPaper 22 October 2012 Pages: 149 - 159
Epidemiology of High Blood Pressure and Obesity Francisco Javier MartínezJose M. Sancho-Rof OriginalPaper 22 October 2012 Pages: 160 - 164
Diagnosis of Insulin Resistance Francisco Javier MartínezEduardo VillaRafael García-Robles OriginalPaper 22 October 2012 Pages: 165 - 171
Hypertension and Insulin Resistance B. WeichenhainH-J. van KootenE. Standl OriginalPaper 22 October 2012 Pages: 183 - 188
Nephroprotective Effect of ACE Inhibitors Stephan OrthMichal NowickiEberhard Ritz OriginalPaper 22 October 2012 Pages: 189 - 196
The Pathogenesis of Hypertension in Obese Subjects Peter WeidmannMaximilian de CourtenSidney Shaw OriginalPaper 22 October 2012 Pages: 197 - 209
New Aspects of Antihypertensive Treatment G. ManciaC. GiannattasioG. Grassi OriginalPaper 22 October 2012 Pages: 210 - 213